| |
| |
|
| Insider
Information: |
Kaufmann Michael C |
| Relationship: |
Director |
| City: |
Dublin |
| State: |
OH |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
613,483 |
|
|
Indirect Shares
|
10 |
|
|
| Direct
Value |
$60,978,749 |
|
|
|
Indirect Value
|
$995 |
|
|
| Total
Shares |
613,493 |
|
|
| Total
Value |
$60,979,745 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cardinal Health Inc |
CAH |
CEO, Director |
2022-08-15 |
601,065 |
2022-08-15 |
10 |
Premium* |
|
|
MSC Industrial Direct Co Inc |
MSM |
Director |
2024-01-26 |
12,418 |
2015-09-24 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
113 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2009-09-15 |
4 |
A |
$27.29 |
$646,800 |
D/D |
23,701 |
64,620 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2010-02-01 |
4 |
D |
$33.07 |
$202,157 |
D/D |
(6,113) |
58,507 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2010-03-15 |
4 |
D |
$34.91 |
$9,321 |
D/D |
(267) |
58,240 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2010-08-15 |
4 |
D |
$31.36 |
$57,452 |
D/D |
(1,832) |
56,408 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2010-08-16 |
4 |
A |
$0.00 |
$0 |
D/D |
21,652 |
78,060 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2010-09-15 |
4 |
D |
$31.79 |
$14,115 |
D/D |
(444) |
77,616 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2010-12-03 |
4 |
S |
$37.29 |
$23,605 |
I/I |
(633) |
0 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2011-02-07 |
4 |
S |
$41.71 |
$3,651,460 |
D/D |
(87,544) |
70,720 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2011-02-07 |
4 |
OE |
$22.90 |
$2,088,983 |
D/D |
80,648 |
158,264 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2011-03-18 |
4 |
OE |
$22.90 |
$4,053 |
D/D |
177 |
70,897 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2011-03-18 |
4 |
AS |
$40.95 |
$7,248 |
D/D |
(177) |
70,720 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2011-04-21 |
4 |
AS |
$42.95 |
$367,652 |
D/D |
(8,560) |
62,160 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2011-04-27 |
4 |
AS |
$43.95 |
$445,785 |
D/D |
(10,143) |
62,160 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2011-04-27 |
4 |
OE |
$32.33 |
$327,923 |
D/D |
10,143 |
72,303 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2011-05-05 |
4 |
AS |
$44.95 |
$455,928 |
D/D |
(10,143) |
62,160 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2011-05-05 |
4 |
OE |
$32.33 |
$327,923 |
D/D |
10,143 |
72,303 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2011-07-01 |
4 |
OE |
$32.33 |
$327,923 |
D/D |
10,143 |
72,303 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2011-07-01 |
4 |
AS |
$45.95 |
$466,071 |
D/D |
(10,143) |
62,160 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2011-08-15 |
4 |
A |
$0.00 |
$0 |
D/D |
18,793 |
80,953 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2011-08-15 |
4 |
D |
$40.87 |
$59,343 |
D/D |
(1,452) |
79,501 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2011-08-16 |
4 |
D |
$41.60 |
$16,848 |
D/D |
(405) |
79,096 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2011-09-15 |
4 |
D |
$41.58 |
$18,462 |
D/D |
(444) |
78,652 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2011-10-26 |
4 |
OE |
$27.29 |
$54,580 |
D/D |
2,000 |
80,652 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2011-10-26 |
4 |
AS |
$44.95 |
$89,900 |
D/D |
(2,000) |
78,652 |
0 |
- |
|
| CAH |
Cardinal Health Inc |
CEO, Pharmaceutical Segment |
• – – |
2011-10-27 |
4 |
OE |
$27.29 |
$1,450,682 |
D/D |
53,158 |
131,810 |
0 |
- |
|
113 Records found
|
|
Page 1 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
